Two very different conditions — one tied to ageing, one to blood sugar — both take aim at the same fragile target: the delicate blood vessels and tissue of the retina. Understanding how each one actually damages the eye explains why early detection matters so much for both.
Cataracts and glaucoma, covered in the previous two articles, damage a lens and a nerve. Age-related macular degeneration and diabetic retinopathy take aim at something different entirely: the retina's own delicate tissue and blood supply — and despite having very different causes, both diseases follow the same basic rule, where the earlier they are caught, the more vision can realistically be saved.
The macula, introduced in the earlier article on retinal anatomy, is a small, densely cone-packed region at the centre of the retina responsible for sharp central vision — reading, recognising faces, driving, and any task requiring fine detail. It represents only a small fraction of the retina's total surface area, yet it does a disproportionate share of the visual system's most demanding work, which is exactly why damage to it, even when localised, can have an outsized effect on someone's daily functioning.
Age-related macular degeneration (AMD) is a progressive deterioration of the macula, and one of the leading causes of central vision loss in people over 60 in much of the world. It exists in two distinct forms with very different mechanisms and outlooks. Dry AMD, accounting for the large majority of cases, involves the gradual thinning of macular tissue and the build-up of tiny yellow deposits called drusen beneath the retina, typically progressing slowly over years. Wet AMD, far less common but considerably more aggressive, occurs when abnormal, fragile blood vessels grow beneath the macula and leak fluid or blood, causing rapid, sometimes severe vision loss over weeks rather than years. Dry AMD can, in a minority of cases, progress into wet AMD, but the reverse does not occur.
Dry AMD develops gradually through drusen build-up beneath the macula. Wet AMD involves abnormal, leaking blood vessels and progresses far more rapidly.
Age is by far the strongest risk factor, with prevalence rising sharply after 60, but several other factors meaningfully raise risk: smoking roughly doubles AMD risk and is the single strongest modifiable factor, a family history of AMD suggests a genetic component, and cardiovascular risk factors such as high blood pressure and high cholesterol are also associated with increased risk. Because AMD affects central rather than peripheral vision, symptoms typically include blurred or distorted central vision — straight lines appearing wavy is a particularly characteristic early symptom — along with difficulty recognising faces, a dark or empty area in central vision, and reduced ability to see in low light.
An Amsler grid, a simple pattern of straight horizontal and vertical lines with a central dot, is sometimes used by patients with AMD or those at higher risk to check for changes at home. If straight lines begin to appear wavy, distorted, or if areas of the grid seem to disappear when focusing on the central dot, this can indicate AMD progression and warrants a prompt appointment — this is a monitoring tool, however, not a diagnostic one, and does not replace a full retinal examination.
AMD is diagnosed through a dilated retinal examination, often combined with optical coherence tomography (OCT), introduced in the earlier article on glaucoma, which produces detailed cross-sectional images capable of revealing drusen, fluid, or abnormal blood vessels beneath the retina with considerable precision. Dry AMD currently has no cure, though specific high-dose vitamin and mineral formulations, based on the large AREDS2 clinical trial, have been shown to modestly slow progression in certain intermediate-stage cases. Wet AMD, despite being the more aggressive form, is actually the more treatable one: regular injections of anti-VEGF medication directly into the eye can shrink abnormal blood vessels and reduce leakage, often stabilising or even improving vision when started promptly — a genuine medical advance that has transformed wet AMD's outlook over the past two decades.
Diabetic retinopathy is damage to the retina's blood vessels caused by prolonged elevated blood sugar, and is a leading cause of vision loss specifically among working-age adults. Persistently high blood sugar gradually weakens and damages the walls of the retina's small blood vessels, causing them to leak fluid or blood, become blocked, or, in more advanced stages, trigger the growth of new, abnormally fragile blood vessels in a desperate attempt to compensate for reduced blood flow. Diabetic retinopathy can affect anyone with diabetes, type 1 or type 2, and risk rises the longer someone has lived with diabetes and the less consistently their blood sugar has been controlled.
Diabetic retinopathy progresses through recognisable stages. Non-proliferative diabetic retinopathy, the earlier stage, involves weakened blood vessel walls that bulge, leak fluid, and sometimes bleed slightly, but without yet growing new abnormal vessels. Proliferative diabetic retinopathy, the more advanced and sight-threatening stage, occurs when the retina, starved of adequate blood flow, triggers growth of fragile new blood vessels that bleed easily and can lead to scar tissue formation, retinal detachment, or severe vision loss. A separate but related complication, diabetic macular edema, occurs when fluid leaks specifically into the macula, and can significantly affect central vision at any stage of the broader disease.
| Stage | What's Happening | Risk Level |
|---|---|---|
| Non-proliferative (early) | Blood vessel walls weaken, bulge, and leak | Lower, but requires monitoring |
| Proliferative (advanced) | Fragile new blood vessels grow abnormally | High risk of bleeding, scarring, retinal detachment |
| Diabetic macular edema | Fluid leaks directly into the macula | Can significantly affect central vision at any stage |
Diabetic retinopathy is diagnosed through a dilated retinal examination, and, as with AMD, OCT and specialised retinal photography help detect and precisely track changes over time. Treatment depends heavily on stage and severity: early, mild non-proliferative disease is often managed primarily through careful blood sugar control and regular monitoring rather than direct eye treatment. More advanced disease may require laser photocoagulation, which uses targeted laser burns to seal leaking vessels or reduce abnormal vessel growth, or anti-VEGF injections similar to those used in wet AMD, to reduce leakage and abnormal vessel growth directly.
Because diabetic retinopathy frequently causes no symptoms until it is relatively advanced, annual dilated eye exams are recommended for essentially everyone with diabetes, regardless of how well vision currently feels — a screening recommendation that exists specifically because meaningful, sight-saving treatment is available if the disease is caught early, but far less effective once significant damage has already occurred.
Neither disease can be entirely prevented, but risk can be meaningfully reduced. For AMD, not smoking is the single most impactful modifiable step, alongside managing blood pressure and cholesterol and eating a diet rich in leafy greens and other AMD-protective nutrients. For diabetic retinopathy, consistent, well-controlled blood sugar is by far the strongest protective factor, alongside managing blood pressure, since both conditions place direct, measurable stress on the same fragile retinal blood vessels. For both diseases, the single most effective safeguard remains the same: regular comprehensive, dilated eye exams, which can detect meaningful changes well before a person notices any change in their own vision.
Age-related macular degeneration and diabetic retinopathy arrive from entirely different directions — one from the slow accumulation of age, the other from years of elevated blood sugar — yet both ultimately threaten the same irreplaceable tissue, and both reward the same simple habit: showing up for a dilated eye exam before any symptoms make the choice feel urgent. By the time either disease announces itself clearly, the most effective window for protecting vision has often already begun to close.
12 questions. Select an answer for each, then submit to see your score instantly.